scPharmaceuticals Inc.Company Review & Valuation

SCPH
Nasdaq

About scPharmaceuticals Inc.

scPharmaceuticals Inc., a clinical-stage pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is Furoscix, a drug-device combination product that is under development for treatment of worsening or decompensaShow moreted heart failure outside of the inpatient setting. Its product pipeline also includes scFurosemide, a loop diuretic for the management of edema in patients with decompensated heart failure; scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company was founded in 2013 and is headquartered in Burlington, Massachusetts.Show less

Industry
Biotechnology
HQ Location
Burlington, Massachusetts

Stock Price

Price data not available for scPharmaceuticals Inc..

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

Basilea Pharmaceutica
Atara Biotherapeutics
Celgene
Apricus Biosciences

back to top